• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
TMO

TMO

Thermo Fisher Scientific Inc.

NYSEHealthcareMedical - Diagnostics & ResearchUS

USD473.95

-8.13 (-1.69%)

Rating:B+

Company Profile

CEO

Marc N. Casper

IPO Date

1980-03-17

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NYSE

Country

US

Market Metrics

Open

$469.31

Prev. Close

$482.08

Day Low

$469.29

Day High

$475.77

52W Low

$385.46

52W High

$643.99

Market Cap

$176.13B

Volume

1.50M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

41.3%

Avg Negative

15.7%

Avg Neutral

43.0%

News Feed

Thermo Fisher Scientific Inc (TMO) Stock Up 6.8% and Still Undervalued -- GF Score: 83/100

gurufocus.com·5/28/2026·↓ negative

Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies

businesswire.com·5/28/2026·↑ positive

Thermo Fisher Scientific Inc. (TMO) Analyst/Investor Day Transcript

seekingalpha.com·5/22/2026
·↑ positive

Thermo Fisher Scientific Announces Quarterly Dividend

businesswire.com·5/20/2026·↑ positive

Thermo Fisher Scientific Highlights Industry Leadership, Growth Outlook and Long-Term Value Creation at 2026 Investor Day

businesswire.com·5/20/2026·↑ positive

Jefferies updates its list of highest-conviction Buy-rated stocks

finbold.com·5/18/2026·↑ positive

Thermo Fisher Scientific's PPD Clinical Research Business Expands Bioanalytical Capabilities with New Laboratory in Gothenburg, Sweden

businesswire.com·5/18/2026·↑ positive

Nalgene Outdoor Introduces Fresh Flow™ Straw Bottle

businesswire.com·5/11/2026·↑ positive

TMO DCF Analysis: Intrinsic Value $478 vs Price $465

gurufocus.com·5/11/2026·↓ negative

Thermo Fisher Scientific's Clinical Research Business Named a Leader Among CROs in 2026 ISG Provider Lens™ Report for Use of AI in Clinical Trials

businesswire.com·5/6/2026·↑ positive